These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1833421

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
    [Abstract] [Full Text] [Related]

  • 25. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 26. Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease.
    Pedersen OD, Gram J, Jespersen J.
    Thromb Haemost; 1995 May; 73(5):835-40. PubMed ID: 7482412
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R, Seitz R, Blanke H, Leititis J, Kesper HJ, Burghard R, Fuchs G, Lerch L.
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [Abstract] [Full Text] [Related]

  • 29. Advances in clinical fibrinolysis.
    Hessel LW, Kluft C.
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The rabbit as a model for studies of fibrinolysis.
    Hassett MA, Krishnamurti C, Barr CF, Alving BM.
    Thromb Res; 1986 Aug 01; 43(3):313-23. PubMed ID: 3488605
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH, Saito H, Ratnoff OS.
    J Clin Invest; 1978 Jul 01; 62(1):54-60. PubMed ID: 659637
    [Abstract] [Full Text] [Related]

  • 39. Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo.
    Derkx FH, Brommer EJ, Boomsma F, Schalekamp MA.
    Clin Exp Hypertens A; 1982 Jul 01; 4(11-12):2247-58. PubMed ID: 6756694
    [Abstract] [Full Text] [Related]

  • 40. Relation of the fibrinolytic to other biological systems.
    Stormorken H.
    Thromb Diath Haemorrh; 1975 Nov 15; 34(2):378-85. PubMed ID: 128149
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.